![](https://webarchive.library.unt.edu/eot2008/20090116014530im_/http://www.cancer.gov/images/spacer.gif) |
|
Adrenocortical Carcinoma - Featured Clinical Trials The following list shows Featured Clinical Trials for a specific type of cancer. You may also want to view:
1. Targeted Combination Therapy for Advanced Solid Tumors (Posted: 07/19/2005) - In this study, researchers are assessing the safety and combined effectiveness of bevacizumab and a second drug called sorafenib. Both bevacizumab and sorafenib inhibit the formation of blood vessels to tumors and may act synergistically when combined.
![](https://webarchive.library.unt.edu/eot2008/20090116014530im_/http://www.cancer.gov/images/spacer.gif)
2. Combination Chemotherapy for Adrenocortical Cancer (Posted: 01/18/2005) - This trial combines a drug called tariquidar with chemotherapy to treat adrenocortical carcinoma. Tariquidar may make cancer cells more sensitive to chemotherapy.
|
|
![](https://webarchive.library.unt.edu/eot2008/20090116014530im_/http://www.cancer.gov/images/spacer.gif) |